Pharmacy Times and U.S. News & World Report honored Cetaphil as the No. 1 Pharmacist Recommended brand in the Therapeutic Skin Care Cleansers category for the third year in a row, Cetaphil said on Thursday. Read More »

National Drug Take-Back Day scheduled for 10 a.m. to 2 p.m. Sept. 26 Read More »

CVS Health and IBM said on Thursday that they will use predictive analytics and cognitive computing to transform care-management services for patients with chronic diseases. Read More »

The California Chamber of Commerce said Wednesday it is opposed to a proposed health care bill because it would restrict the ability of health insurers and pharmacy benefit managers (PBM) to control health care costs and would place strict caps on prescription drug copayments, therefore shifting costs, encouraging utilization of expensive medications and reducing flexibility. Read More »

Centric Health Corporation, a Canadian healthcare services company, announced on Wednesday that A. Rik Ganderton will be appointed as an independent member of the board of directors, effective Aug. 5. Read More »

The National Community Pharmacists Association (NCPA) has submitted comments in response to the Medicaid managed care proposed rule from the Centers for Medicare and Medicaid Services, expressing the need for improvements within the proposal. Read More »

Part D costs per capita grew by almost 11 percent in 2014. Read More »

The Utilization Review Accreditation Commission (URAC) has opened a public comment period through Aug. 31 on measurement standards related to its line of pharmacy accreditation products. Read More »

The Government Accountability Office (GAO) released a report Monday that found better communications with pharmacies and other stakeholders can help control prescription drug abuse while guaranteeing that patient access to medications is not compromised. The report studied the interaction between the Drug Enforcement Agency (DEA) and government and industry stakeholders in curbing prescription drug abuse and preserving patient access to medications. Read More »

California Assembly Bill 339 aims to rein in prescription-drug prices to ease the economic impact on those with chronic medical conditions who need expensive drugs, but critics are warning that it also would increase insurance premiums for everyone else and make it harder for insurers to obtain lower-cost drugs. Read More »

Gerresheimer AG, a partner to the pharma and health care industry worldwide, announced today it will extend its pharmaceutical packaging business with the acquisition of Centor US Holding, Inc. Read More »

Data from the 2014 United Benefit Advisors (UBA) Health Plan Survey released Tuesday shows a substantial increase in the use of 4-tier plans that usually cover the highest cost drugs and major increases in corresponding median copays. Read More »

Deal includes more than 200 offices specializing in occupational health, medical exams and urgent care Read More »

Atlantic Information Services, leaders from SCAN and Express Scripts and a consultant with industry experience will explain how they were able to achieve strong results from their joint MA-PBM program during a webinar on Aug. 6. Read More »

Praxsyn Corp. today announced that the board of directors has appointed Justin Cary as the company's chief financial officer, effective immediately. Read More »

Teva Pharmaceutical Industries, Ltd. announced Monday it has signed a definitive agreement with Allergan, PLC to acquire Allergan Generics in a transaction valued at $40.5 billion.The strategic acquisition brings together two leading generics businesses with complementary strengths, brands and cultures. Read More »

Rite Aid has recently collaborated with HealthSpot to deploy telepresence pharmacy kiosks at 25 Rite Aid pharmacies across Ohio. Read More »

The U.S. Food and Drug Administration late last week approved Praluent injections, the first cholesterol-lowering treatment cleared for use in a new class of drugs known as proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors. Read More »

Covance Drug Development recently relocated its Dallas clinical research unit to a new, fit-for-purpose clinical research facility in the same building. Read More »

Mike Pritts, executive vice president of product innovation at Surescripts, recently wrote a blog post touting the importance of IT automation to the healthcare industry. Read More »